"Dendritic Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).
Descriptor ID |
D003713
|
MeSH Number(s) |
A11.066.270 A11.436.270 A15.382.066.270 A15.382.812.260
|
Concept/Terms |
Dendritic Cells- Dendritic Cells
- Cell, Dendritic
- Cells, Dendritic
- Dendritic Cell
Interstitial Dendritic Cells- Interstitial Dendritic Cells
- Cell, Interstitial Dendritic
- Cells, Interstitial Dendritic
- Dendritic Cell, Interstitial
- Interstitial Dendritic Cell
- Dendritic Cells, Interstitial
Veiled Cells- Veiled Cells
- Cell, Veiled
- Cells, Veiled
- Veiled Cell
Plasmacytoid Dendritic Cells- Plasmacytoid Dendritic Cells
- Cell, Plasmacytoid Dendritic
- Cells, Plasmacytoid Dendritic
- Dendritic Cell, Plasmacytoid
- Plasmacytoid Dendritic Cell
- Dendritic Cells, Plasmacytoid
Interdigitating Cells- Interdigitating Cells
- Cell, Interdigitating
- Cells, Interdigitating
- Interdigitating Cell
- Interdigitating Dendritic Cells
- Dendritic Cells, Interdigitating
- Cell, Interdigitating Dendritic
- Cells, Interdigitating Dendritic
- Dendritic Cell, Interdigitating
- Interdigitating Dendritic Cell
|
Below are MeSH descriptors whose meaning is more general than "Dendritic Cells".
Below are MeSH descriptors whose meaning is more specific than "Dendritic Cells".
This graph shows the total number of publications written about "Dendritic Cells" by people in this website by year, and whether "Dendritic Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 |
1996 | 1 | 1 | 2 |
1997 | 2 | 3 | 5 |
1998 | 0 | 2 | 2 |
1999 | 4 | 1 | 5 |
2000 | 2 | 0 | 2 |
2001 | 5 | 2 | 7 |
2002 | 6 | 2 | 8 |
2003 | 12 | 2 | 14 |
2004 | 7 | 6 | 13 |
2005 | 10 | 7 | 17 |
2006 | 13 | 6 | 19 |
2007 | 10 | 8 | 18 |
2008 | 7 | 4 | 11 |
2009 | 7 | 7 | 14 |
2010 | 6 | 2 | 8 |
2011 | 8 | 11 | 19 |
2012 | 11 | 8 | 19 |
2013 | 15 | 10 | 25 |
2014 | 11 | 8 | 19 |
2015 | 10 | 9 | 19 |
2016 | 13 | 11 | 24 |
2017 | 6 | 5 | 11 |
2018 | 3 | 1 | 4 |
2019 | 9 | 3 | 12 |
2020 | 5 | 6 | 11 |
2021 | 4 | 6 | 10 |
2022 | 2 | 1 | 3 |
2023 | 2 | 7 | 9 |
2024 | 4 | 5 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dendritic Cells" by people in Profiles.
-
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 Nov 26; 8(22):5796-5805.
-
Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy. J Immunother Cancer. 2024 Oct 26; 12(10).
-
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance. Clin Cancer Res. 2024 Oct 01; 30(19):4450-4463.
-
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect. Clin Cancer Res. 2024 Jul 15; 30(14):2857-2859.
-
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity. Nat Commun. 2024 Jun 28; 15(1):5487.
-
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy. Cell Rep. 2024 May 28; 43(5):114141.
-
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells. Adv Sci (Weinh). 2024 Apr; 11(14):e2308280.
-
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS Nano. 2024 Feb 13; 18(6):5152-5166.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Human serous cavity macrophages and dendritic cells possess counterparts in the mouse with a distinct distribution between species. Nat Immunol. 2024 Jan; 25(1):155-165.